GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zafgen Inc (NAS:ZFGN) » Definitions » Price-to-Tangible-Book

Zafgen (Zafgen) Price-to-Tangible-Book : 0.73 (As of Apr. 26, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Zafgen Price-to-Tangible-Book?

As of today (2024-04-26), Zafgen's share price is $0.99. Zafgen's Tangible Book per Share of Mar. 2020 for the quarter that ended in Mar. 2020 was $1.35. Hence, Zafgen's Price to Tangible Book Ratio of today is 0.73.

The historical rank and industry rank for Zafgen's Price-to-Tangible-Book or its related term are showing as below:

ZFGN's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.68
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Zafgen's share price is $0.99. Zafgen's Book Value per Sharefor the quarter that ended in Mar. 2020 was $1.35. Hence, Zafgen's P/B Ratio of today is 0.73.


Zafgen Price-to-Tangible-Book Historical Data

The historical data trend for Zafgen's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zafgen Price-to-Tangible-Book Chart

Zafgen Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only 12.16 8.57 19.49 23.75 9.30

Zafgen Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.90 7.39 5.54 9.30 6.82

Competitive Comparison of Zafgen's Price-to-Tangible-Book

For the Biotechnology subindustry, Zafgen's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zafgen's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zafgen's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Zafgen's Price-to-Tangible-Book falls into.



Zafgen Price-to-Tangible-Book Calculation

Zafgen's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2020 )
=0.99/1.354
=0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Zafgen Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Zafgen's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Zafgen (Zafgen) Business Description

Traded in Other Exchanges
N/A
Address
3 Center Plaza, Suite 610, Boston, MA, USA, 02108
Zafgen Inc is a US-based biopharmaceutical company. It focuses on developing novel therapeutics that treat the underlying biological mechanisms through the methionine aminopeptidase 2, or MetAP2, pathway. The lead product candidate of the company is ZGN-1061 which is a novel fumagillin-class MetAP2 inhibitor administered by subcutaneous injection. The company operates in the business of developing novel therapeutics. The company primarily carries its business operations in the United States.